Navigation Links
Rush University Medical Center experts present latest research findings at AAOS meeting
Date:2/25/2009

(CHICAGO) Leading orthopedic surgeons and other clinicians from Rush University Medical Center are presenting new basic and clinical research findings at the American Academy of Orthopaedic Surgeons annual meeting in Las Vegas, Nev., on February 25-28. Highlights from some of the educational sessions led by orthopedic experts from Rush as well as some of the podium and poster presentations to be made by physicians from Rush include:

Dr. Joshua Jacobs Joint Reconstruction

  • Educational session: Current Controversies in Bearing Surface Science, Wednesday, February 25, 8 a.m.
  • Educational session: Technology 2009: Alternative Bearing Surfaces: The Good, Bad and Indifferent, Wednesday, February 25, 1:30 p.m.
  • Educational session: Revision in Total Hip Arthroplasty: Understanding and Management of Osteolysis, Thursday, February 26, 10:30 a.m.
  • Educational session: Worldwide Perspective on Hip Resurfacing, Thursday, February 26, 4 p.m.
  • Scientific session: Local Metal Reactions after Metal-Metal Hip Arthroplasty, Saturday, February 28, 8:29 a.m.

Dr. Howard An Spine, Back and Neck

  • Educational session: Avoiding and Managing Complications in Cervical Spine Surgery, Wednesday, February 25, 10:30 a.m.

Dr. Bernard Bach Sports Medicine

  • Scientific session: Instability: Bone Grafts and Complications Normalization of Glenohumeral Articular Contact Pressures after Either Latarject or Iliac Crest Bone Grafting Procedure: Impact of Graft Type, Positions, and Coracoid Orientation, Sautrday, February 28, 11:20 a.m.

Dr. Richard BergerJoint Reconstruction

  • Educational session: Partial Arthroplasty of the Knee, Thursday, February 26, 8 a.m.
  • Podium presentation: Problems from Allowing Knee Replacement to be Discharged the Day of Surgery, Thursday, February 26, 12:06 p.m.
  • Educational session: MIS THA/TKA?
    '/>"/>

Contact: Deb Song
deb_song@rush.edu
312-942-0588
Rush University Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Boston University School of Medicine receives grant
2. University of the Rockies Introduces Mental Health Administration Specialization for Psych Majors
3. 2009 DeLee Humanitarian Award goes to Marshall Lindheimer, M.D., of the University of Chicago
4. Case Western Reserve University faculty named 2009 NorTech Innovation Award winner
5. Physicians Practice and University of Cincinnati Physicians Partner to Improve Patient Care in Cincinnati, Ohio
6. Herzing College, Orlando Will Change Name to Herzing University and Host Sign-Changing Event on March 2, 2009
7. University of Texas engineers receive $3.2 million in National Science Foundation CAREER awards
8. Rice Universitys Baker Institute experts available to discuss stem cell research, recommendations
9. University of the Basque Country team develop nano-hydrogels capable of detecting cancer cells
10. University of Ottawa Heart Institute Scientists Unlock Mechanism That Turns on Weight-Loss Gene
11. HotHead Technologies Heat Sensor Shows Exciting Potential by Kennesaw State University Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Hand Surgeons Take Ethics into Their Own Hands 2Hand Surgeons Take Ethics into Their Own Hands 3Hand Surgeons Take Ethics into Their Own Hands 4Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4National Patient Safety Foundation Supports Mandatory Flu Vaccinations for Healthcare Workers 61647 1National Patient Safety Foundation Supports Mandatory Flu Vaccinations for Healthcare Workers 61647 2National Patient Safety Foundation Supports Mandatory Flu Vaccinations for Healthcare Workers 61647 3Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 1Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 2Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 3Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 4Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 5Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 6Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 7Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 8Improving Quality Cost Effectiveness and Time Savings in Preclinical Inhalable Formulation Development 6386 1Improving Quality Cost Effectiveness and Time Savings in Preclinical Inhalable Formulation Development 6386 2